肌萎缩
鞘脂
神经酰胺
丝氨酸
生物
神经酰胺合酶
药理学
内科学
酶
内分泌学
生物化学
医学
细胞凋亡
作者
Johanne Poisson,Ioanna Daskalaki,Vijay Potluri,Jean‐David Morel,Sandra Rodríguez-López,Alessia De Masi,Giorgia Benegiamo,Suresh Jain,Tanes Lima,Johan Auwerx
标识
DOI:10.1021/acsptsci.4c00587
摘要
The accumulation of ceramides and related metabolites has emerged as a pivotal mechanism contributing to the onset of age-related diseases. However, small molecule inhibitors targeting the ceramide de novo synthesis pathway for clinical use are currently unavailable. We synthesized a safe and orally bioavailable inhibitor, termed ALT-007, targeting the rate-limiting enzyme of ceramide de novo synthesis, serine palmitoyltransferase (SPT). In a mouse model of age-related sarcopenia, ALT-007, administered through the diet, effectively restored muscle mass and function compromised by aging. Mechanistic studies revealed that ALT-007 enhances protein homeostasis in Caenorhabditis elegans and mouse models of aging and age-related diseases, such as sarcopenia and inclusion body myositis (IBM); this effect is mediated by a specific reduction in very-long chain 1-deoxy-sphingolipid species, which accumulate in both muscle and brain tissues of aged mice and in muscle cells from IBM patients. These findings unveil a promising therapeutic avenue for developing safe ceramide inhibitors to address age-related neuromuscular diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI